AU5902901A - Il-17 receptor like molecules and uses thereof - Google Patents

Il-17 receptor like molecules and uses thereof

Info

Publication number
AU5902901A
AU5902901A AU5902901A AU5902901A AU5902901A AU 5902901 A AU5902901 A AU 5902901A AU 5902901 A AU5902901 A AU 5902901A AU 5902901 A AU5902901 A AU 5902901A AU 5902901 A AU5902901 A AU 5902901A
Authority
AU
Australia
Prior art keywords
receptor
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU5902901A
Inventor
Shuqian Jing
Eugene Medlock
Richard Yeh
Scott M Silbiger
Gary S Elliot
Hung Q Nguyen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU5902901A publication Critical patent/AU5902901A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU5902901A 2000-03-16 2001-03-16 Il-17 receptor like molecules and uses thereof Pending AU5902901A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18992300P 2000-03-16 2000-03-16
US20420800P 2000-05-12 2000-05-12
US72323200A 2000-11-27 2000-11-27
US26615901P 2001-02-02 2001-02-02
PCT/US2001/008688 WO2001068705A2 (en) 2000-03-16 2001-03-16 Il-17 receptor like molecules and uses thereof

Publications (1)

Publication Number Publication Date
AU5902901A true AU5902901A (en) 2001-09-24

Family

ID=27497823

Family Applications (2)

Application Number Title Priority Date Filing Date
AU5902901A Pending AU5902901A (en) 2000-03-16 2001-03-16 Il-17 receptor like molecules and uses thereof
AU2001259029A Ceased AU2001259029B2 (en) 2000-03-16 2001-03-16 Il-17 receptor like molecules and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001259029A Ceased AU2001259029B2 (en) 2000-03-16 2001-03-16 Il-17 receptor like molecules and uses thereof

Country Status (8)

Country Link
EP (1) EP1265924A2 (en)
JP (1) JP2003527117A (en)
AR (1) AR030554A1 (en)
AU (2) AU5902901A (en)
CA (1) CA2401273A1 (en)
MX (1) MXPA02009024A (en)
TW (1) TWI322154B (en)
WO (1) WO2001068705A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69936382T3 (en) 1998-05-15 2011-07-07 Genentech, Inc., Calif. THERAPEUTIC USES OF IL-17 HOMOLOGOUS POLYPEPTIDE
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
DK1897944T3 (en) * 1999-12-23 2011-10-24 Genentech Inc IL-17 homologous polypeptides and their therapeutic use
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2007202616B2 (en) * 2000-06-22 2011-08-18 Amgen Inc. IL-17 Like Molecules and Uses Thereof
EP1326626B1 (en) 2000-10-18 2020-04-01 Immunex Corporation Methods for treating rheumatoid arthritis using il-17 antagonists
WO2004013281A2 (en) * 2002-08-05 2004-02-12 Eli Lilly And Company Novel proteins and their uses
EP1562587A4 (en) * 2002-09-11 2006-07-19 Genentech Inc Novel compositions and methods for the treatment of immune related diseases
CA2638864A1 (en) * 2006-02-10 2007-10-18 Zymogenetics, Inc. Truncated il-17ra soluble receptor and methods of using in inflammation
US7767206B2 (en) 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
WO2008067057A2 (en) * 2006-10-13 2008-06-05 The Regents Of The University Of California Cancer treatment
US8454955B2 (en) * 2007-11-28 2013-06-04 Riken Methods for treating allergic airway inflammation, airway hypersensitivity, and eosinophilia
KR20150002874A (en) 2008-05-05 2015-01-07 노비뮨 에스 에이 Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
GB0905972D0 (en) 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
EP2427203B1 (en) 2009-05-05 2018-10-17 Novimmune S.A. Anti-il-17f antibodies and use thereof
LT2523688T (en) 2010-01-15 2018-03-12 Kirin-Amgen, Inc. Antibody formulation and therapeutic regimens
LT2552961T (en) * 2010-03-30 2018-02-12 Janssen Biotech, Inc. Humanized il-25 antibodies
US9284283B2 (en) 2012-02-02 2016-03-15 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating IL-17

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5106627A (en) 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5319071A (en) 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
WO1989004838A1 (en) 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
DE69233441T2 (en) 1991-04-26 2005-10-13 Osaka Bioscience Institute, Suita Human cell surface antigen encoding DNA
US5489743A (en) 1993-01-19 1996-02-06 Amgen Inc. Transgenic animal models for thrombocytopenia
EP0700435A1 (en) 1993-05-26 1996-03-13 Ontario Cancer Institute Transgenic mammals lacking expression of particular cd45 isoforms
US6664107B1 (en) 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid
WO1995001997A1 (en) 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
WO1996020206A1 (en) 1994-12-23 1996-07-04 Uab Research Foundation Secreted human fas antigen
WO1996041865A1 (en) 1995-06-07 1996-12-27 Ariad Gene Therapeutics, Inc. Rapamcycin-based regulation of biological events
EP0888303B1 (en) 1996-02-28 2010-04-21 ARIAD Pharmaceuticals, Inc Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
EP1015488B1 (en) * 1997-09-17 2009-09-09 Human Genome Sciences, Inc. Interleukin-17 receptor-like protein
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
AU2315099A (en) * 1998-01-09 1999-07-26 Immunex Corporation Il-17rh dna and polypeptides
AU3207000A (en) * 1999-01-11 2000-08-01 Schering Corporation Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses
CA2367378A1 (en) * 1999-04-05 2000-10-12 Incyte Pharmaceuticals, Inc. Molecules of the immune system
AU2001236638A1 (en) * 2000-02-04 2001-08-14 The Board Of Trustees Of The University Of Arkansas Evi27 gene sequences and protein encoded thereby
AU784727B2 (en) * 2000-02-08 2006-06-01 Amgen, Inc. IL-17 like molecules and uses thereof
US9100155B2 (en) 2010-05-03 2015-08-04 Qualcomm Incorporated Method and apparatus for control and data multiplexing in wireless communication
JP6160461B2 (en) 2013-11-29 2017-07-12 富士通株式会社 Likelihood weighting circuit

Also Published As

Publication number Publication date
WO2001068705A3 (en) 2002-07-18
CA2401273A1 (en) 2001-09-20
EP1265924A2 (en) 2002-12-18
WO2001068705A2 (en) 2001-09-20
MXPA02009024A (en) 2003-02-12
JP2003527117A (en) 2003-09-16
AR030554A1 (en) 2003-08-27
AU2001259029B2 (en) 2006-01-05
TWI322154B (en) 2010-03-21

Similar Documents

Publication Publication Date Title
AU7296801A (en) Il-17 molecules and uses thereof
HUS1300012I1 (en) Soluble ctla4 mutant molecules and uses thereof
AU5902901A (en) Il-17 receptor like molecules and uses thereof
AU5720601A (en) Bispecific molecules and uses thereof
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
MXPA02012749A (en) B7-like molecules and uses thereof.
IL151853A (en) Multivalent antibodies and uses thereof
AU3662101A (en) Cd40-binding apc-activating molecules
AU9667901A (en) Mycoattractants and mycopesticides
AU4196801A (en) Chordin-like-2 molecules and uses thereof
IL154553A0 (en) Urocortin-iii and uses thereof
EP1147213A4 (en) Novel rgs-containing molecules and uses thereof
MXPA03007270A (en) G-protein coupled receptor molecules and uses thereof.
AU2001262963A1 (en) Laminin 15 and uses thereof
GB0115780D0 (en) Therapeutic molecules and uses thereof
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
GB0022670D0 (en) Molecules
TW457995U (en) Bending and forming device
IL153653A0 (en) Novel therapeutic molecular variants and uses thereof
GB0013345D0 (en) Modified receptor and assay
GB0002625D0 (en) Dendroaspin molecules
GB0013185D0 (en) Films and uses thereof
AU7161801A (en) B7-like molecules and uses thereof
GB0028126D0 (en) Polymer and uses thereof
EP1437367A4 (en) Antibody and use thereof